inflammatory linear verrucous epidermal nevus
MONDO:0019318
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Inflammatory linear verrucous epidermal nevus
Inflammatory linear verrucous epidermal nevus (ILVEN) is an uncommon skin (cutaneous) disorder characterized by itchy (pruritic), red (erythematous) and raised (hyperkeratotic) plaques that follow the lines of skin cell development (Blaschko lines). The rash typically presents in infancy or early childhood, with a female predominance and most frequently affects the lower limbs. ILVEN is caused by somatic mutations during the embryonic stage that results in visible genetic mosaicism. There is no cure, but different medical treatments can alleviate the symptoms. The plaques can vary significantly, but tend to be slightly warty (psoriaform) or scaly (eczema-like).
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.